Table 3.
Safety of Inactivated COVID-19 Vaccination in PLWH
| Characteristics | Patients (n=47) |
|---|---|
| Injection site adverse reactions within 7 days | |
| Pain, n (%) | 3 (6.4) |
| Swollen, n (%) | 2 (4.2) |
| Local redness, n (%) | 2 (4.2) |
| Systemic adverse reactions within 7days | |
| Fatigue, n (%) | 3 (6.4) |
| Headache, n (%) | 3 (6.4) |
| Muscle soreness, n (%) | 3 (6.4) |
| Fever, n (%) | 2 (4.2) |
| Diarrhea, n (%) | 1 (2.1) |
| Nausea, n (%) | 0 (0.0) |
| Total adverse reaction within 28 days | |
| Any, n (%) | 9 (19.1) |